Abstract
Lipopolysaccharide (LPS) or endotoxin, the major cell wall component of Gram-negative bacteria, plays a pivotal role in the pathogenesis of sepsis. It is able to activate the host defense system through interaction with Toll-like receptor 4, thus triggering pro-inflammatory mechanisms. A large amount of LPS induces inappropriate activation of the immune system, triggering an exaggerated inflammatory response and consequent extensive organ injury, providing the basis of sepsis damage. In this review, we will briefly describe endotoxin’s molecular structure and its main pathogenetic action during sepsis. In addition, we will summarize the main different available methods for endotoxin detection with a special focus on the wider spectrum offered by omics technologies (genomics, transcriptomics, proteomics, and metabolomics) and promising applications of these in the identification of specific biomarkers for sepsis.
Reference84 articles.
1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3);Singer;JAMA J. Am. Med. Assoc.,2016
2. The Enigma of Sepsis;Riedemann;J. Clin. Investig.,2003
3. New Insight in LPS Antagonist;Ianaro;Mini Rev. Med. Chem.,2009
4. Sondhi, P., Maruf, M.H.U., and Stine, K.J. (2019). Nanomaterials for Biosensing Lipopolysaccharide. Biosensors, 10.
5. Assessment of Global Incidence and Mortality of Hospital-Treated Sepsis. Current Estimates and Limitations;Fleischmann;Am. J. Respir. Crit. Care Med.,2016
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献